Zobrazeno 1 - 10
of 42
pro vyhledávání: '"J R Seibold"'
Autor:
Suzanne Kafaja, Philip J. Clements, Holly Wilhalme, Chi-hong Tseng, Daniel E. Furst, Grace Hyun Kim, Jonathan Goldin, Elizabeth R. Volkmann, Michael D. Roth, Donald P. Tashkin, Dinesh Khanna, Ann Arbor, D. Khanna, Los Angeles, P. J. Clements, D. P. Tashkin, R. Elashoff, J. Goldin, M. Roth, D. Furst, K. Bulpitt, W.-L. J. Chung, S. Viasco, M. Sterz, L. Woolcock, X. Yan, J. Ho, S. Vasunilashorn, I. da Costa, J. R. Seibold, D. J. Riley, J. K. Amorosa, V. M. Hsu, D. A. McCloskey, J. E. Wilson, J. Varga, D. Schraufnagel, A. Wilbur, D. Lapota, S. Arami, P. Cole-Saffold, R. Simms, A. Theodore, P. Clarke, J. Korn, K. Tobin, M. Nuite, R. Silver, M. Bolster, C. Strange, S. Schabel, E. Smith, J. Arnold, K. Caldwell, M. Bonner, R. Wise, F. Wigley, B. White, L. Hummers, M. Bohlman, A. Polito, G. Leatherman, E. Forbes, M. Daniel, V. Steen, C. Read, C. Cooper, S. Wheaton, A. Carey, A. Ortiz, M. Mayes, E. Parsley, S. Oldham, T. Filemon, S. Jordan, M. Perry, null K. Connolly, J. Golden, P. Wolters, R. Webb, J. Davis, C. Antolos, C. Maynetto, B. Fessler, M. Olman, C. Sanders, L. Heck, T. Parkhill, N. Rothfield, M. Metersky, R. Cobb, M. Aberles, F. Ingenito, E. Breen, K. Mubarak, J. L. Granda, J. Silva, Z. Injic, R. Alexander, S. Springmeyer, S. Kirkland, J. Molitor, R. Hinke, A. Mondt, T. Thompson, S. Rounds, M. Weinstein, B. Thompson, H. Paulus, S. Levy, D. Martin, E. Kissin, F. Y. Cheong, G. Marlis, J. Mason-Berry, P. Saffold, M. Rodriguez, L. Guzman, J. Brook, G. Ibrahim, K. Largaespada, C. Fridley, M. Zulmastashvili, A. Manu, S. Moore, F. N. Hant, K. Gibson, M. Morrison, H. Donnelly, C. Marlin, J. Gangar, A. Eller, D. Leong, M. Lalosh, J. Obata, D. Franklin, E. Schiopu, M. Benedict-Blue, V. Leone, J. Shaw, F. Tan, J. Anderson, A. Saulino, P. Carey, M. Esplin, P. Carlson
Publikováno v:
American journal of respiratory and critical care medicine. 197(5)
Rationale: FVC percent predicted (FVC%) is the primary outcome measure in clinical trials of systemic sclerosis interstitial lung disease. For interpretation of change in the FVC% over time, it is important to define whether these changes are clinica
Autor:
D, Khanna, Ma, Tan, D E, Furst, N S, Hill, V V, McLaughlin, R M, Silver, V D, Steen, A, Langer, J R, Seibold, Barbara, Segal
Publikováno v:
Clinical and experimental rheumatology. 32(6 Suppl 86)
The aim of this study was to utilise the Quality Enhancement Research Initiative in Systemic Sclerosis (QuERI-SSc) to measure and reduce a perceived gap in the diagnosis of pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc
Autor:
A J, Impens, J, Rothman, E, Schiopu, J C, Cole, J, Dang, N, Gendrano, R C, Rosen, J R, Seibold
Publikováno v:
Clinical and experimental rheumatology. 27(3 Suppl 54)
Few studies exist on sexual activity and functioning in female patients with systemic sclerosis (SSc, scleroderma). We studied the patient-reported impact of SSc on sexual functioning among female patients.101 SSc patients completed the Short Form-36
In October of 2007, a group of true experts in diverse areas relevant to scleroderma were invited to Florence, Italy for a 2-day symposium on ‘Controversies in Scleroderma’. As the organizing committee for this activity, we selected the topics an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46f3fa8fb6459ed7f294509a4182af68
https://www.zora.uzh.ch/id/eprint/154781/
https://www.zora.uzh.ch/id/eprint/154781/
Publikováno v:
Clinical and experimental rheumatology. 21(3 Suppl 29)
This report makes recommendations for standardized techniques of data gathering and collection regarding: 1) skin involvement 2) joint and tendon involvement, and 3) involvement of the skeletal muscles. The recommendations in this report derive from
Autor:
J E, Pope, N, Bellamy, J R, Seibold, M, Baron, M, Ellman, S, Carette, C D, Smith, I M, Chalmers, P, Hong, D, O'Hanlon, E, Kaminska, J, Markland, J, Sibley, L, Catoggio, D E, Furst
Publikováno v:
Arthritis and rheumatism. 44(6)
Early diffuse scleroderma (systemic sclerosis; SSc) has no proven treatment. This study was undertaken to examine the efficacy of methotrexate (MTX) in improving the skin and other disease parameters in early diffuse SSc.Seventy-one patients with dif
Publikováno v:
The Journal of rheumatology. 26(6)
Accelerated nodulosis is a recognized complication of methotrexate (MTX) therapy in rheumatoid arthritis (RA). We describe 3 patients with accelerated nodulosis treated with D-penicillamine (D-Pen) while continuing MTX. The combination of D-Pen with
Autor:
P J, Clements, D E, Furst, W K, Wong, M, Mayes, B, White, F, Wigley, M H, Weisman, W, Barr, L W, Moreland, T A, Medsger, V, Steen, R W, Martin, D, Collier, A, Weinstein, E, Lally, J, Varga, S, Weiner, B, Andrews, M, Abeles, J R, Seibold
Publikováno v:
Arthritis and rheumatism. 42(6)
To test the hypothesis that systemic sclerosis (SSc) patients taking high-dose D-penicillamine (D-Pen) would have greater softening of skin, lower frequency of renal crisis, and better survival than patients taking low-dose D-Pen.Seventeen centers en
Autor:
J R, Seibold, P J, Clements, D E, Furst, M D, Mayes, D A, McCloskey, L W, Moreland, B, White, F M, Wigley, S, Rocco, M, Erikson, J F, Hannigan, M E, Sanders, E P, Amento
Publikováno v:
The Journal of rheumatology. 25(2)
To investigate the safety and pharmacokinetics of a 28 day continuous subcutaneous infusion of recombinant human relaxin in patients with systemic sclerosis with diffuse scleroderma.Thirty patients with stable diffuse scleroderma of moderate severity
Autor:
D E, Furst, P J, Clements, V D, Steen, T A, Medsger, A T, Masi, W A, D'Angelo, P A, Lachenbruch, R G, Grau, J R, Seibold
Publikováno v:
The Journal of rheumatology. 25(1)
To test the ability of the modified Rodnan skin score to reflect skin thickness in skin biopsies from 141 patients with systemic sclerosis (SSc) obtained at entry during a prospective, double blind study of ketanserin versus placebo in SSc.Punch skin